ICSI has a rigorous process for developing and maintaining evidence-based guidelines and protocols. Learn more about our program:
Evidence Quality and Recommendations
ICSI utilizes the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system as a method of assessing the quality of evidence and writing recommendations for guidelines. This provides advantages over other systems including a system previously used/developed by ICSI. Learn more.
In 2011, the IOM released updated recommendations on the best methods or standards to promote consistency and trustworthiness of CPGs across developers. These standards and ICSI’s guideline development framework are designed to:
- Combat bias
- Enhance transparency
- Highlight benefits and harms
- Promote optimal patient outcomes
- Provide cost-effective care options that enhance the patient experience
- Limit practice variation through strong recommendations and care options.
ICSI is committed to meeting these standards in all of our guideline work.
Conflict of Interest Policy
ICSI requires the disclosure of all real or potential conflicts of interest by everyone who serves on work groups and review committees charged with developing, maintaining and approving its scientific documents. This disclosure must be made periodically or if a change in personal circumstances causes the previously submitted disclosure to be inaccurate. Even if a person is uncertain whether a conflict of interest exists, such potential conflicts must be routinely disclosed. Learn more.
Importance of a Strong Conflict of Interest Policy
As pointed out in this New York Times article Doctors’ Magical Thinking About Conflicts of Interest, about the Food & Drug Administration's review process, scientific document reviewers can be swayed by varying levels of conflict of interest.